ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
AstraZeneca Pharma India Limited received an order from the ROC, Bengaluru, imposing a total penalty of ₹0.03 Crore for a delayed filing. The company is evaluating next steps.
AstraZeneca Pharma disclosed a ₹1.88 lakh penalty from the Registrar of Companies due to a delay in filing Form MR-2.
The Delhi High Court has stayed the NPPA's demand notice regarding Betaloc-50 overcharging allegations until February 2027, subject to a 15% deposit of the total demand amount.
AstraZeneca Pharma received a Rs. 148.66 Crore demand notice from the NPPA for alleged overcharging. The company is currently evaluating the notice and potential legal actions.
AstraZeneca Pharma received a demand notice from the NPPA for Rs. 0.80 Crore regarding alleged overcharging under the Drugs (Prices Control) Order, 2013.